Codetta Biosciences, a Morrisville, NC-based supplier of a digital spatial polymerase chain response (dsPCR) and digital spatial immuno polymerase chain response (dsiPCR) platform, raised $15M in Collection A funding.
The spherical was led by Anzu Companions with participation from Genoa Ventures and VC23 LLC.
The corporate intends to make use of the funds to speed up the event of its multi-omic dsPCR platform and scale up its workforce in R&D, engineering, advertising and marketing, and enterprise administration.
Led by TJ Johnson, CEO, Codetta Biosciences is a life sciences firm growing a digital spatial polymerase chain response (dsPCR) and digital spatial immuno polymerase chain response (dsiPCR) platform for multi-omic evaluation from a single specimen. Its built-in platform of reagents, {hardware}, and software program permits simultaneous, multi-plexed, and multi-omic analyses of liquid biopsy and remoted DNA, RNA and protein. The know-how permits researchers to investigate viral and bacterial targets, mutations, and deletions, in addition to gene and protein expression extra effectively than standard applied sciences, offering extra high-quality information from a single specimen whereas sustaining a easy sample-to-answer workflow.
FinSMEs
08/04/2022
